Search research articles
Contact Us
Filters
Showing results (101-110 of 114) with videos related to
Page
of 12
Sort By:
Cellular & Molecular Immunology
|
November 3, 2020
Low serum neutralizing anti-SARS-CoV-2 S antibody levels in mildly affected COVID-19 convalescent patients revealed by two different detection methods
Berislav Bošnjak, Saskia Catherina Stein, Stefanie Willenzon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 19, 2023
Incidence of Hypertension and Blood Pressure Changes in Persons With Human Immunodeficiency Virus at High Risk for Cardiovascular Disease Switching From Boosted Protease Inhibitors to Dolutegravir: A Post-hoc Analysis of the 96-week Randomised NEAT-022 Trial
Abiu Sempere, Lambert Assoumou, Ana González-Cordón, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 19, 2022
Limited Weight Impact After Switching From Boosted Protease Inhibitors to Dolutegravir in Persons With Human Immunodeficiency Virus With High Cardiovascular Risk: A Post Hoc Analysis of the 96-Week NEAT-022 Randomized Trial
Laura Waters, Lambert Assoumou, Ana González-Cordón, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 16, 2021
Humoral and Cellular Immune Responses Against Severe Acute Respiratory Syndrome Coronavirus 2 Variants and Human Coronaviruses After Single BNT162b2 Vaccination
Metodi V Stankov, Anne Cossmann, Agnes Bonifacius, et al.
Ebiomedicine
|
December 31, 2023
Systems biology analysis reveals distinct molecular signatures associated with immune responsiveness to the BNT162b COVID-19 vaccine
Ivan Odak, Lennart Riemann, Inga Sandrock, et al.
Nature Medicine
|
July 15, 2021
Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination
Joana Barros-Martins, Swantje I Hammerschmidt, Anne Cossmann, et al.
Immunity
|
February 10, 2021
COVID-19 immune signatures reveal stable antiviral T cell function despite declining humoral responses
Agnes Bonifacius, Sabine Tischer-Zimmermann, Anna C Dragon, et al.
Frontiers in Immunology
|
August 1, 2022
Host KIR/HLA-C Genotypes Determine HIV-Mediated Changes of the NK Cell Repertoire and Are Associated With Vpu Sequence Variations Impacting Downmodulation of HLA-C
Sarah Vollmers, Annabelle Lobermeyer, Annika Niehrs, et al.
Nature Communications
|
August 18, 2022
BNT162b2-boosted immune responses six months after heterologous or homologous ChAdOx1nCoV-19/BNT162b2 vaccination against COVID-19
Georg M N Behrens, Joana Barros-Martins, Anne Cossmann, et al.
Infection
|
July 31, 2025
Performance of whole blood interferon-γ release assays in SARS-CoV-2 and tuberculosis is age dependent
Tobias Rothoeft, Anna Teresa Hoffmann, Christoph Maier, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 114) with videos related to
Sort By:
Page
of 12
Cellular & Molecular Immunology
|
November 3, 2020
Low serum neutralizing anti-SARS-CoV-2 S antibody levels in mildly affected COVID-19 convalescent patients revealed by two different detection methods
Berislav Bošnjak, Saskia Catherina Stein, Stefanie Willenzon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 19, 2023
Incidence of Hypertension and Blood Pressure Changes in Persons With Human Immunodeficiency Virus at High Risk for Cardiovascular Disease Switching From Boosted Protease Inhibitors to Dolutegravir: A Post-hoc Analysis of the 96-week Randomised NEAT-022 Trial
Abiu Sempere, Lambert Assoumou, Ana González-Cordón, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 19, 2022
Limited Weight Impact After Switching From Boosted Protease Inhibitors to Dolutegravir in Persons With Human Immunodeficiency Virus With High Cardiovascular Risk: A Post Hoc Analysis of the 96-Week NEAT-022 Randomized Trial
Laura Waters, Lambert Assoumou, Ana González-Cordón, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 16, 2021
Humoral and Cellular Immune Responses Against Severe Acute Respiratory Syndrome Coronavirus 2 Variants and Human Coronaviruses After Single BNT162b2 Vaccination
Metodi V Stankov, Anne Cossmann, Agnes Bonifacius, et al.
Ebiomedicine
|
December 31, 2023
Systems biology analysis reveals distinct molecular signatures associated with immune responsiveness to the BNT162b COVID-19 vaccine
Ivan Odak, Lennart Riemann, Inga Sandrock, et al.
Nature Medicine
|
July 15, 2021
Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination
Joana Barros-Martins, Swantje I Hammerschmidt, Anne Cossmann, et al.
Immunity
|
February 10, 2021
COVID-19 immune signatures reveal stable antiviral T cell function despite declining humoral responses
Agnes Bonifacius, Sabine Tischer-Zimmermann, Anna C Dragon, et al.
Frontiers in Immunology
|
August 1, 2022
Host KIR/HLA-C Genotypes Determine HIV-Mediated Changes of the NK Cell Repertoire and Are Associated With Vpu Sequence Variations Impacting Downmodulation of HLA-C
Sarah Vollmers, Annabelle Lobermeyer, Annika Niehrs, et al.
Nature Communications
|
August 18, 2022
BNT162b2-boosted immune responses six months after heterologous or homologous ChAdOx1nCoV-19/BNT162b2 vaccination against COVID-19
Georg M N Behrens, Joana Barros-Martins, Anne Cossmann, et al.
Infection
|
July 31, 2025
Performance of whole blood interferon-γ release assays in SARS-CoV-2 and tuberculosis is age dependent
Tobias Rothoeft, Anna Teresa Hoffmann, Christoph Maier, et al.
Page
of 12